This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Quest Diagnostics To Showcase Its Award-Winning Healthcare IT Connectivity Solutions At HIMSS13

Stocks in this article: DGX

NEW ORLEANS , March 5, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is presenting its award-winning healthcare information technology (HIT) connectivity solutions at HIMSS13.  Quest Diagnostics offers the broadest access to diagnostic information services through its network of laboratories and through its HIT network which connects acute and ambulatory environments, spans more than 310,000 physicians in over 95,000 offices and is interoperable with 15,000 EMR connections with more than 200 vendors. 

Advanced healthcare IT solutions are critical to meet the demands of health systems as stakeholders seek to meaningfully improve healthcare, drive efficiency, and accelerate interoperability among acute and ambulatory environments. Quest Diagnostics HIT connectivity solutions support multiple healthcare stakeholders, integrate platforms, and optimize workflows strategically across health systems. The result is a connected healthcare system with access to critical diagnostic insights through an open, compatible secure network.  

"Our HIT platform was developed to provide healthcare professionals with a comprehensive suite of interoperable HIT solutions and programs that support informed decision making, allowing users to be smart, synchronized and connected," said Philip S. Present, Vice President and General Manager, Care360 Products.   "With Quest Diagnostics' leadership in the delivery of large-scale clinical information, complete with Six Sigma quality and security, we are committed to putting knowledge in the hands of the providers, the patient, payers and their communities of care."

The key pillars of Quest Diagnostic's connectivity platforms are being showcased at the HIMSS 2013 Conference this week in New Orleans at booth #3927, where the company's HIT executives and healthcare thought-leaders will share the company's HIT solutions that address the top priorities of CIOs and CFOs: health system efficiency and enhanced connectivity.

Quest Diagnostics executives are showcasing the following HIT tools:



1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.97 +225.60 1.31%
S&P 500 2,021.43 +19.27 0.96%
NASDAQ 4,682.1450 +44.1510 0.95%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs